Research map: Arrhythmias associated with immune checkpoint inhibitor therapy—A clinical perspective

Back to the article

Papers in this map

  1. Cancer immunotherapy using checkpoint blockade · Antoni Ribas · 2018 · 6969 citations · Cited by this paper
  2. Activation of sigma non‐opioid intracellular receptor 1 (S1R) receptor inhibits plexin domain containing 2 (Plxdc2) driven microglial inflammation to ameliorate depressive‐like behaviours in mice · 2026 · Related
  3. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death · Katja Zeppenfeld · 2022 · 3137 citations · Cited by this paper
  4. Unmasking the Rare but Lethal Cardiac Complications of Immune Checkpoint Inhibitor Therapy: A Review of Mechanisms, Risk Factors, and Management Strategies · 2025 · Related
  5. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) · Alexander Richard Lyon · 2022 · 3064 citations · Cited by this paper
  6. Acute anaphylactic and multiorgan inflammatory effects of Comirnaty in pigs: evidence of spike protein mRNA transfection and paralleling inflammatory cytokine upregulation · 2026 · Related
  7. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) · Isabelle C. Van Gelder · 2024 · 2934 citations · Cited by this paper
  8. A novel quinoline and manganese‐based carbon monoxide‐releasing molecule for intravesical therapy of bladder cancer · 2026 · Related
  9. Fulminant Myocarditis with Combination Immune Checkpoint Blockade · Douglas Buckner Johnson · 2016 · 2337 citations · Cited by this paper
  10. Serotonin engages divergent 5‐HT receptor pathways for cell type‐resolved modulation of prefrontal layer 5 microcircuits · 2026 · Related
  11. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. · Matthew F. Krummel · 1995 · 2250 citations · Cited by this paper
  12. Decoding functional specialization in G protein‐coupled receptors (GPCRs) through evolution‐guided residue profiling · 2026 · Related
  13. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy · Michael Glikson · 2021 · 1995 citations · Cited by this paper
  14. Thirty‐day dapagliflozin therapy improves the nanomechanical properties of red blood cells in patients with type 1 diabetes · 2026 · Related
  15. Immune Checkpoint Inhibitors in Cancer Therapy · Yavar Shiravand · 2022 · 1367 citations · Cited by this paper
  16. Targeting sphingosine‐1‐phosphate receptor‐2 attenuates spinal cord injury by preventing neuronal ferroptosis · 2026 · Related
  17. Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study · Joe‐Elie Salem · 2018 · 1266 citations · Cited by this paper
  18. Virtual cell construction for artificial intelligence‐driven drug discovery · 2026 · Related
  19. Immune checkpoint therapy—current perspectives and future directions · Padmanee Sharma · 2023 · 1195 citations · Cited by this paper
  20. A covalent peptide engager approach to equip immunotherapeutic monoclonal and pan IgG serum antibodies with new tumour‐targeting function · 2026 · Related
  21. Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis · Javid J. Moslehi · 2018 · 947 citations · Cited by this paper
  22. Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society · Alexander Richard Lyon · 2020 · 832 citations · Cited by this paper
  23. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. · Peter S. Linsley · 1990 · 756 citations · Cited by this paper
  24. Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia · Joerg Herrmann · 2020 · 751 citations · Cited by this paper
  25. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation · Stylianos E. Tzeis · 2024 · 626 citations · Cited by this paper
  26. Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis · Shrujal S. Baxi · 2018 · 586 citations · Cited by this paper
  27. Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints · Lee‐Shing Chang · 2018 · 535 citations · Cited by this paper
  28. Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor–Related Cardiotoxicity · Marion Escudier · 2017 · 527 citations · Cited by this paper
  29. Cardiovascular toxicities associated with immune checkpoint inhibitors · Jiun‐Ruey Hu · 2019 · 520 citations · Cited by this paper
  30. Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non–Small Cell Lung Cancer · Bairavi Shankar · 2020 · 500 citations · Cited by this paper
  31. 2025 ESC Guidelines for the management of myocarditis and pericarditis · Jeanette Schulz‐Menger · 2025 · 410 citations · Cited by this paper
  32. Insights Into Onco-Cardiology · Dimitrios T. Farmakis · 2013 · 395 citations · Cited by this paper
  33. Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC) · Jelena Čelutkienė · 2020 · 374 citations · Cited by this paper
  34. Role of Serum Biomarkers in Cancer Patients Receiving Cardiotoxic Cancer Therapies: A Position Statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology · Radek Pudil · 2020 · 360 citations · Cited by this paper
  35. T cells specific for α-myosin drive immunotherapy-related myocarditis · Margaret L. Axelrod · 2022 · 351 citations · Cited by this paper
  36. Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor–Associated Myocarditis · Lili Zhang · 2020 · 282 citations · Cited by this paper
  37. Cardiovascular Toxicities of Immune Checkpoint Inhibitors · Somedeb Ball · 2019 · 224 citations · Cited by this paper
  38. Ipilimumab · Fiona H. Cameron · 2011 · 215 citations · Cited by this paper
  39. Immune Checkpoint Inhibitor–Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases · Ranjan Pathak · 2021 · 210 citations · Cited by this paper

Source: OpenAlex (CC0)